Management of atypical cranial meningiomas, Part 2: Predictors of progression and the role of adjuvant radiation after subtotal resection

Neurosurgery

Volumn 75, Issue 4, 2014, Pages 356-363

  Sun, Sam Q ^a   Cai, Chunyu ^b   Murphy, Rory K J ^b   Dewees, Todd ^b   Dacey, Ralph G ^b   Grubb, Robert L ^b   Rich, Keith M ^b   Zipfel, Gregory J ^b   Dowling, Joshua L ^b   Leuthardt, Eric C ^b   Leonard, Jeffrey R ^b   Evans, John ^b   Simpson, Joseph R ^b   Robinson, Clifford G ^b   Perrin, Richard J ^b   Huang, Jiayi ^b   Chicoine, Michael R ^b   Kim, Albert H ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Adjuvant; Local therapy; Meningioma mortality; Meningioma pathology; Meningioma therapy; Neoplasm recurrence; Radiation tolerance; Radiotherapy; Retrospective studies

Indexed keywords

ADULT; ARTICLE; ATYPICAL MENINGIOMA; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; MENINGIOMA; NECROSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOSENSITIVITY; RETROSPECTIVE STUDY; RISK FACTOR; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME; ADJUVANT THERAPY; AGED; DISEASE COURSE; DISEASE FREE SURVIVAL; MENINGEAL NEOPLASMS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; RADIOSURGERY;

ADULT; AGED; COHORT STUDIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECROSIS; RADIOSURGERY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 84924086706     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000462     Document Type: Article

References (24)

1. Jo K, Park HJ, Nam DH, et al. Treatment of atypical meningioma. J Clin Neurosci. 2010;17(11):1362-1366.
2. Goyal LK, Suh JH, Mohan DS, Prayson RA, Lee J, Barnett GH. Local control and overall survival in atypical meningioma: A retrospective study. Int J Radiat Oncol Biol Phys. 2000;46(1):57-61.
3. Hardesty DA, Wolf AB, Brachman DG, et al. The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection: clinical article. J Neurosurg. 2013;119(2):475-481.
4. Choi CY, Soltys SG, Gibbs IC, et al. Cyberknife stereotactic radiosurgery for treatment of atypical (WHO grade II) cranial meningiomas. Neurosurgery. 2010; 67(5):1180-1188.
5. Modha A, Gutin PH. Diagnosis and treatment of atypical and anaplastic meningiomas: A review. Neurosurgery. 2005;57(3):538-550.
6. Rogers L, Gilbert M, Vogelbaum MA. Intracranial meningiomas of atypical (WHO grade II) histology. J Neurooncol. 2010;99(3):393-405.
7. Lee KD, DePowell JJ, Air EL, Dwivedi AK, Kendler A, McPherson CM. Atypical meningiomas: is postoperative radiotherapy indicated? Neurosurg Focus. 2013;35(6):E15.
8. Park HJ, Kang HC, Kim IH, et al. The role of adjuvant radiotherapy in atypical meningioma. J Neurooncol. 2013;115(2):241-247.
9. Marcus HJ, Price SJ, Wilby M, Santarius T, Kirollos RW. Radiotherapy as an adjuvant in the management of intracranial meningiomas: Are we practising evidence-based medicine? Br J Neurosurg. 2008;22(4):520-528.
10. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109.
11. Turkbey B, Mani H, Aras O, et al. Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol. 2012;188(4):1157-1163.
12. Hakyemez B, Yildirim N, Erdogan C, Kocaeli H, Korfali E, Parlak M. Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation? Neuroradiology. 2006; 48(10):695-702.
13. Perry A, Chicoine MR, Filiput E, Miller JP, Cross DT. Clinicopathologic assessment and grading of embolized meningiomas. Cancer. 2001;92(3):701-711.
14. Mair R, Morris K, Scott I, Carroll TA. Radiotherapy for atypical meningiomas: clinical article. J Neurosurg. 2011;115(4):811-819.
15. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. Meningioma grading: An analysis of histologic parameters. Am J Surg Pathol. 1997;21(12): 1455-1465.
16. Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 2004;4(6):437-447.
17. Rockwell S, Dobrucki IT, Kim EY, Marrison ST, Vu VT. Hypoxia and radiation therapy: past history, ongoing research, and future promise. Curr MolMed. 2009;9 (4):442-458.
18. Pasquier D, Bijmolt S, Veninga T, et al. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients: A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys. 2008;71(5):1388-1393.
19. Detti B, Scoccianti S, Di Cataldo V, et al. Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients. J Neurooncol. 2013;115 (3):421-427.
20. Aghi MK, Carter BS, Cosgrove GR, et al. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery. 2009;64(1):56-60.
21. Hawasli AH, Bagade S, Shimony JS, Miller-Thomas M, Leuthardt EC. Magnetic resonance imaging-guided focused laser interstitial thermal therapy for intracranial lesions: Single-institution series. Neurosurgery. 2013;73:1007-1017.
22. Yoo H, Baia GS, Smith JS, et al. Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas. Clin Cancer Res. 2007;13(1):68-75.
23. Sheehan J, Cifarelli CP, Dassoulas K, Olson C, Rainey J, Han S. Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide: laboratory investigation. J Neurosurgery. 2010;113(2):234-239.
24. Alexander BM, Ligon KL, Wen PY. Enhancing radiation therapy for patients with glioblastoma. Expert Rev Anticancer Ther. 2013;13(5):569-581.